Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Name: Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
License: Public Domain

Centre Hospitalier Universitaire de Besancon

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hepatocellular carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 325129
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.